Skip to main content
OpenTrials

Clinical trial condition

Clostridium Difficile Infection Recurrence

Explore clinical trials studying Clostridium Difficile Infection Recurrence. Study availability and eligibility vary by location and protocol.

10 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Clostridium Difficile Infection Recurrence trial results

Recruiting

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

NCT07513285

Conditions
Clostridium Difficile Infection Recurrence
Locations
  • UC Davis Medical Center Sacramento, California, United States
  • Gastroenterolgy Center of Conneticut Hamden, Connecticut, United States
  • Florida International Medical Research Coral Gables, Florida, United States
  • L&A Morales Healthcare, Inc Hialeah, Florida, United States
View all 15 locations
View Trial Details
Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT06237452

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, C. Diff Infection, +17 more
Locations
  • Metro Infectious Disease Consultants Huntsville, Alabama, United States
  • Advanced Gastroenterology, P.C. Chandler, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • GI Alliance Sun City, Arizona, United States
View all 215 locations
View Trial Details
Completed

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

NCT05831189

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Difficile Infection Recurrence, +13 more
Locations
  • Ferring Investigational Site North Little Rock, Arkansas, United States
  • Ferring Investigational Site Camarillo, California, United States
  • Ferring Investigational Site Hamden, Connecticut, United States
  • Ferring Investigational Site Idaho Falls, Idaho, United States
View Trial Details
Completed

Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT03788434

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, CDI, +9 more
Locations
  • Phoenix Clinical, LLC Phoenix, Arizona, United States
  • Mayo Clinic, Clinical Studies Unit Phoenix, Arizona, United States
  • NEA Baptist Clinic Jonesboro, Arkansas, United States
  • Alliance Research Institute Canoga Park, California, United States
View all 37 locations
View Trial Details
Completed

A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)

NCT04891965

Conditions
Clostridium Difficile Infection Recurrence
Locations
  • Palmtree Clinical Research Palm Springs, California, United States
  • Gastro Florida Clearwater, Florida, United States
  • Doral Medical Research Doral, Florida, United States
  • Louisiana Research Center Shreveport, Louisiana, United States
View all 15 locations
View Trial Details
Completed

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

NCT03110133

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Difficile Infection Recurrence, +13 more
Locations
  • Scottsdale Scottsdale, Arizona, United States
  • Los Angeles Los Angeles, California, United States
  • Murrieta Murrieta, California, United States
  • Oakland Oakland, California, United States
View all 58 locations
View Trial Details

Related conditions